Great Elm's NAV Crack: The CLO That Was the Strategy Becomes the Drag

A 7% NAV markdown, an incentive fee that came back, and a dividend no longer covered — yet management's answer is to keep buying its own stock at a third off book.

GECC · Earnings Call · 2026-11-03

The CLO JV, once the crown jewel, is now the write-down

For several quarters the CLO JV sat at the center of the Great Elm story — a differentiated, proprietary exposure to a diversified pool of first-lien loans that most small BDCs couldn't replicate. This quarter it became the single largest line item dragging NAV down. Net asset value fell roughly 7% to $7.40 per share from $7.95, and $3.3 million of that came from marking down the CLO Formation JV. Jason Reese was direct about the cause, and notably, it wasn't credit: “one of the underlying CLOs had some significant triple C exposure, which that has been marked down. The real driver of those values is the discount rate that the third-party valuation experts use.” — Jason Reese, Chief Executive Officer · 2026-11-03 That distinction matters. Management is arguing this is a discount-rate and CCC-bucket problem, not a borrower problem, and in the same breath insists “the underlying credit quality of our portfolio remains strong.” — Jason Reese, Chief Executive Officer · 2026-11-03 Both can be true — but the market only marks the equity. The JV still holds majority positions in three CLOs covering roughly $1.1 billion of first-lien loans and has thrown off about $25 million of cumulative distributions since inception. The issue is that in a market where “spreads in the BSL market are very tight” — Jason Reese, Chief Executive Officer · 2026-11-03 but CLO equity marks are sliding, the thing that was supposed to be the durable cash engine is now the volatile one. Common equity stood near $110 million at the last filing, down 21% year-over-year, and the market has already priced the rest: shares trade near 0.7x book, versus a level above 1.0x as recently as last year.

Coverage breaks — and the fee waiver quietly disappears

The headline number is ugly in a way that matters for an income vehicle: net investment income of $0.17 per share against a $0.25 distribution. Reese conceded it: “You're right, $0.17 is more sustainable... We also think we're probably at the low point.” — Jason Reese, Chief Executive Officer · 2026-11-03 The company points to two one-time drags — a $2 million insurance-linked dividend that landed in Q2 and didn't recur, plus the return of incentive fee accruals that had been waived. That second item is the story. The reinstatement of incentive accruals after three quarters of waivers removes a crutch that had been quietly flattering results. A quarter ago the same management team closed the call by saying the company had “generated net investment income that fully covered our dividend” — Jason Reese, Chief Executive Officer · 2026-08-06 — a claim it cannot make today. Analysts have been circling this exact question for a year; in May, Reese was pressed on whether he'd keep waiving fees if run-rate earnings fell short, and answered that the team would “continue looking at what's in the best interest of the shareholders... we definitely want to be covering our dividend.” — Jason Reese, CEO and Executive Chairman · 2026-05-05 Now the waiver is gone and the dividend isn't covered on a quarterly basis. The bridge he offers is spillover taxable income, which he says is “significant” — Jason Reese, Chief Executive Officer · 2026-11-03 but undisclosed — a soft cushion for a hard number.

The buyback is the whole capital-allocation argument

With respect to where the money goes, the answer has collapsed to one option. GECC has bought back ~350,000 shares year-to-date at an average of $4.96 — a 33% discount to the $7.40 NAV — and Reese was unusually blunt about why:

Right now, it is 66% or trading at 66% of our NAV. Buying back some stock is the best thing for the shareholders.
Jason Reese, Chief Executive Officer · 2026-11-03

He's not wrong on the math, and the repurchase shares program is genuinely accretive. But it's also a tell. Retiring your own paper at a 33% discount only beats originating loans when you don't much like the loan market — and this call was explicit that management has been deliberately idle: “We've been seeing this market disruption coming, and so we've been pretty passive about putting our excess capital to work.” — Jason Reese, Chief Executive Officer · 2026-11-03 That's the same posture shareholders have heard for three straight quarters, dressed differently each time. In March, a private investor practically begged the board to buy back more stock; Reese promised the board was “taking this very seriously and looking at this every day.” — Jason Reese, Executive Chairman · 2026-03-03 A year on, the discount has only widened. The deleveraging story is real — total debt down to roughly $154.9 million from $194.4 million at year-end, no maturities until 2029, asset coverage stable at 166.3% — but liabilities still sit at about 61% of assets, and with fixed-rate liabilities against floating-rate assets, higher rates help the spread only if credit holds.

Private credit: a real pivot, but not a new one

The genuine forward-looking thread is the rotation into private credit. Reese called the pipeline “as great as it has been for private loans right now” — Jason Reese, Chief Executive Officer · 2026-11-03, with three private transactions closed in the quarter (~$9 million) and no appetite for new CLO equity because returns on new deals aren't compelling. Underwriting language has tightened into disciplined underwriting — better spreads, higher in the cap structure, better documentation. That's coherent. But it is emphatically not new: the same pivot appeared in Q2 ("definitely moving more towards private credit from BSL") and Q1. It is a well-worn script. And the risk is the one Mickey Schleien named directly — what happens to credit issues if the forward curve is right and rates keep climbing? Reese's answer — sell what worries you — is easier said with a $69 million market cap than done. What's left is a small, deeply discounted specialty finance vehicle betting that NAV stability returns before the spillover cushion runs out. The specialty finance distributions rising tenfold is real, and the CoreWeave stake returning roughly $10.3 million against a $6 million cost is a good trade. But the narrative this quarter is one of a strategy paying for its own marks — and a dividend that now depends on a buyback, a spillover balance nobody will quantify, and a CLO mark that needs discount rates to cooperate. Watch the Q4 NII print against the $0.25 distribution; that's the whole thesis in one line.